Omega-3 Fatty Acids and Muscle Protein Synthesis

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT00794079
Collaborator
Longer Life Foundation (Other), American Federation for Aging Research (Other), Reliant Pharmaceuticals (Industry)
43
1
2
42
1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether omega-3 fatty acid supplementation influences muscle protein synthesis rates in young and older adults.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: omega-3 fatty acids
  • Dietary Supplement: corn oil
N/A

Detailed Description

Loss of muscle mass is a normal consequence of aging. The decline in muscle mass is estimated to be 0.2-0.5% per year from 60 years old onwards in healthy subjects with the decline worsened by chronic illness, poor appetite and diet, and reduced physical activity in the elderly. Increased morbidity is demonstrable with as little as a 5% loss of muscle mass - therefore, treatments that can prevent or slow the progression of muscle loss with aging are much desired.

A major cause for loss of muscle mass in advanced age appears to be an impaired ability to stimulate the synthesis of muscle protein in response to increased levels of amino acids (the building blocks of proteins) and insulin as occurs after eating because of low-grade inflammation and insulin resistance in muscle of old persons. We propose that long-chain omega-3 polyunsaturated fatty acids (fish oil) slow the loss of muscle mass because fish oil has anti-inflammatory properties and increases the sensitivity of muscle protein synthesis to insulin and amino acids. We will test this by studying the effect of fish oil supplementation on the muscle protein synthesis process in young and older adults.

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Omega-3 Fatty Acids and Muscle Protein Synthesis
Study Start Date :
Jun 1, 2007
Actual Primary Completion Date :
Dec 1, 2010
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

omega-3 fatty acids

Dietary Supplement: omega-3 fatty acids
4 grams per day for 8 weeks
Other Names:
  • Lovaza
  • Placebo Comparator: B

    corn oil

    Dietary Supplement: corn oil
    4 grams per day for 8 weeks

    Outcome Measures

    Primary Outcome Measures

    1. Evaluate the effect of omega-3 fatty acid supplementation on skeletal muscle protein synthesis rates both in the basal, postabsorptive state and in response to infusion of insulin and amino acids in young and older adults [Measurements taken prior to and following 8 weeks of supplementation]

    Secondary Outcome Measures

    1. Evaluate the effect of omega-3 fatty acid supplementation on anabolic signaling pathways in skeletal muscle [Measurements taken prior to and following 8 weeks of supplementation]

    2. Evaluate the effect of omega-3 fatty acid supplementation on inflammatory cytokines in the systemic circulation and inflammatory signaling pathways in skeletal muscle [Measurements taken prior to and following 8 weeks of supplementation]

    3. Compare muscle protein synthesis rates between men and women in the basal, postabsorptive state and in response to insulin and amino acid infusion [prior to supplementation only]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Body mass index (BMI) < 30 kg/m2;

    • Age 18-45 yr; or

    • Age 65-85 yr

    Exclusion Criteria:
    • Those taking medications known to affect substrate metabolism or medications that may confound the findings from our study (synthetic steroids, glucocorticoids etc.);

    • Those with evidence of significant organ system dysfunction (e.g. diabetes mellitis, cirrhosis, hypo- or hyperthyroidism; hypertension);

    • Body mass index > 30 kg/m2

    • Age <18 yr, 45-65 yr or > 85 yr

    • Those performing >1.5h of exercise/wk

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Washington University in Saint Louis Saint Louis Missouri United States 63110

    Sponsors and Collaborators

    • Washington University School of Medicine
    • Longer Life Foundation
    • American Federation for Aging Research
    • Reliant Pharmaceuticals

    Investigators

    • Principal Investigator: Bettina Mittendorfer, PhD, Washington University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00794079
    Other Study ID Numbers:
    • 06-1147
    First Posted:
    Nov 19, 2008
    Last Update Posted:
    Aug 3, 2011
    Last Verified:
    Aug 1, 2011
    Keywords provided by , ,

    Study Results

    No Results Posted as of Aug 3, 2011